The Role of Mitochondrial Energetics and Inflammasome NLRP3 in Diabetic Cardiomyopathy
Maha Almas, Usaal Tahir, Mariam Zameer, Maham Mazhar, Qurban Ali, Ayesha Rafique, Khushbukhat Khan
Journal of Pharmaceutical Research International · pp. 309–315 · Published 2 Sep 2021
10.9734/jpri/2021/v33i42B32449Abstract
Diabetic Cardiomyopathy is the worldwide leading cause of lethal heart disorders burdening the healthcare systems. Mitochondrion is the key regulator of myocardial metabolism. It fuels the cardiocytes and regulates the pumping activity of heart. People living with diabetes have defected myocardial metabolism which may likely to cause ventricular dysfunction or other heart disorders due to mitochondrial DNA (mtDNA) mutation. Furthermore, the inflammatory injury due to inflammasome activation is a potent contributor to the cardiac injuries. Though the mechanism of inflammation is still poorly known. This review highlights the association of altered mitochondrial energetics and inflammasome activation with cardiomyopathies.
Cited by 0
No indexed citations yet.
Related research
- Diabetic Cardiomyopathy: A Mini Review of Pathophysiology, Diagnosis, and Therapeutic Strategies — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.